These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

734 related items for PubMed ID: 14696468

  • 1. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
    Lu W, Li Y, He X, Chen Y.
    Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468
    [Abstract] [Full Text] [Related]

  • 2. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
    Lu W, Li YH, Yu ZJ, He XF, Chen Y, Zhao JB, Zhu ZY.
    Hepatogastroenterology; 2007; 54(77):1499-502. PubMed ID: 17708284
    [Abstract] [Full Text] [Related]

  • 3. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
    Lu W, Li YH, He XF, Zhao JB, Chen Y, Mei QL.
    Cardiovasc Intervent Radiol; 2008; 31(6):1133-40. PubMed ID: 18584240
    [Abstract] [Full Text] [Related]

  • 4. [Transcatheter arterial chemoembolization technique in cirrhotic patients with hepatocarcinoma. Considerations on the procedure and evaluation of survival].
    Roversi R, Milandri GL, Ricci S, Rossi G, Dal Monte PR.
    Radiol Med; 1994 Dec; 88(6):834-9. PubMed ID: 7878244
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
    Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M.
    Cancer; 2000 Apr 01; 88(7):1574-81. PubMed ID: 10738215
    [Abstract] [Full Text] [Related]

  • 7. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y, Liver Cancer Study Group of Japan.
    Gastroenterology; 2006 Aug 01; 131(2):461-9. PubMed ID: 16890600
    [Abstract] [Full Text] [Related]

  • 8. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L.
    Am J Clin Oncol; 2003 Aug 01; 26(4):e92-9. PubMed ID: 12902905
    [Abstract] [Full Text] [Related]

  • 9. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
    Bayraktar Y, Balkanci F, Kayhan B, Uzunalimoglu B, Gokoz A, Ozisik Y, Gurakar A, Van Thiel DH, Firat D.
    Hepatogastroenterology; 1996 Aug 01; 43(9):681-7. PubMed ID: 8799415
    [Abstract] [Full Text] [Related]

  • 10. [External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
    Liu MZ, Wang XS, Cai L, Gu MF, Liu H, Li Q, Cui NJ, Zhang YQ, Li GH, Li JQ.
    Ai Zheng; 2005 Jan 01; 24(1):82-6. PubMed ID: 15642207
    [Abstract] [Full Text] [Related]

  • 11. Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma.
    Lu W, Li YH, He XF, Chen Y, Zeng QL, Qiu YR.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun 01; 22(6):524-6. PubMed ID: 12297475
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
    Wu DH, Chen LH.
    Ai Zheng; 2004 Jul 01; 23(7):825-8. PubMed ID: 15248921
    [Abstract] [Full Text] [Related]

  • 13. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF, Chan AO, Wong BC, Hui CK, Ooi GC, Tso WK, Yuan HJ, Wong DK, Lai CL.
    Am J Gastroenterol; 2003 May 01; 98(5):1181-5. PubMed ID: 12809846
    [Abstract] [Full Text] [Related]

  • 14. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A, Cristofori C, Cardin R, Pivetta G, Ragazzi R, Baldan A, Girardi L, Cillo U, Burra P, Giacomin A, Farinati F.
    Am J Gastroenterol; 2008 Apr 01; 103(4):914-21. PubMed ID: 18177453
    [Abstract] [Full Text] [Related]

  • 15. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW.
    Rofo; 2004 Dec 01; 176(12):1794-802. PubMed ID: 15573291
    [Abstract] [Full Text] [Related]

  • 16. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J, Wu Z, Tang Z.
    Zhonghua Wai Ke Za Zhi; 2001 Oct 01; 39(10):745-8. PubMed ID: 16201184
    [Abstract] [Full Text] [Related]

  • 17. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
    Kang IK, Kim SW, Hahn SH, Cho SC, Gham CW, Lee DH.
    Taehan Kan Hakhoe Chi; 2002 Jun 01; 8(2):189-200. PubMed ID: 12499805
    [Abstract] [Full Text] [Related]

  • 18. A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Peng ZW, Chen MS, Liang HH, Gao HJ, Zhang YJ, Li JQ, Zhang YQ, Lau WY.
    Eur J Surg Oncol; 2010 Mar 01; 36(3):257-63. PubMed ID: 19643561
    [Abstract] [Full Text] [Related]

  • 19. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhou ZH, Liu LM, Cheng WW, Meng ZQ, Lin JH, Chen Z, Zhang XJ, Jiang GL.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar 01; 28(3):222-6. PubMed ID: 16875612
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW, Park YM, Bae SH, Choi JY, Yoon SK, Chang UI, Nam SW, Kim BS.
    Cancer Chemother Pharmacol; 2004 Nov 01; 54(5):415-20. PubMed ID: 15235823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.